Gerard Sanacora, MD, PhD
Yale Depression Research Program, Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut
- 13Articles
- 113KReads
- 2004–2026Active
- 83Collaborators
- 718Citations
About
Gerard Sanacora, MD, PhD, is affiliated with the Yale Depression Research Program in the Department of Psychiatry at Yale School of Medicine. His publications from 2004 to 2026 focus on major depressive disorder, bipolar disorder, suicide, electroconvulsive therapy, obsessive-compulsive and related disorders, and psychotherapy. He has contributed extensively to research on ketamine and esketamine treatments, glutamatergic agents as antidepressants, and the mechanisms of action of bipolar medications.
Publications
CBT following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial
May 4, 2026
Comparing the Cognitive Effects of Repeated IV Ketamine and ECT in Patients with Treatment-Resistant Depression: A Secondary Analysis of the ELEKT-D Trial
September 3, 2025
Effect of Benzodiazepines on Antidepressant Effects of Ketamine
November 14, 2022
Ketamine as a Clinical Treatment for Mood Disorders
July 24, 2018
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.